Loading people...
Paul Silber is Principal at Blu Venture Investors, based in Baltimore, MD, USA.
Paul Silber is a Founding Principal and Executive Committee Member at Blu Venture Investors, a venture capital firm based in the Mid-Atlantic region. Before transitioning to venture capital, he spent 15 years as the Founder, President, and CEO of In Vitro Technologies, scaling the business until its $30 million acquisition in 2006. At Blu Venture Investors, he helps manage over $200 million in deployed capital across nearly 80 active portfolio companies, recently participating in a $7 million seed round for SplxAI. Silber is also an active member of the Baltimore Angels and serves as a board director or advisor for several regional startups, including PathSensors and Encore Path. Equipped with a doctorate in pharmacology and toxicology alongside a master's degree in public health, Silber focuses his investments on early-stage healthcare, biotechnology, and enterprise software companies.
